Literature DB >> 9042040

Nasal polyposis: immunohistochemistry and bioelectrical findings (a hypothesis for the development of nasal polyps).

J M Bernstein1, J Gorfien, B Noble, J R Yankaskas.   

Abstract

Nasal polyps and turbinates were obtained from individuals undergoing surgery for symptomatic nasal obstruction caused by nonatopic rhinosinusitis or allergic rhinosinusitis. One part of the tissue from each patient was fixed in neutral buffered formalin and prepared for study by histochemical and immunohistochemical methods. Monoclonal antibodies were used to identify macrophages, lymphocytes, and plasma cells. In most cases (12 of 16, 75%) the remainder of the polyp and turbinate samples was treated with protease to achieve disaggregation of the epithelial cells. Those cells were cultured on permeable collagen matrix supports. Transepithelial potential difference and resistance were measured daily. At the time of maximal transepithelial potential difference, the epithelial cells were mounted in modified. Ussing chambers and exposed to a sodium-positive channel blocker (amiloride hydrochloride) and to selected chloride-negative channel agonists (isoproterenol bitartrate and adenosine triphosphate). Middle turbinates and polyps were found to have more macrophages, lymphocytes, plasma cells, HLA-DR-positive cells, and eosinophils than the inferior turbinates. Epithelial cells obtained from polyps exhibited higher transepithelial potential differences and equivalent short-circuit currents than turbinate cell cultures. The responses to amiloride, isoproterenol, and adenosine triphosphate were also greater for polyp than for turbinate cultures. A theory for the pathogenesis of nasal polyps is proposed. Local release of inflammatory mediators could cause sodium absorption and chloride permeability to be higher in polyps than in turbinate epithelia. Increased sodium absorption is consistent with the hypothesis that epithelial fluid absorption contributes to the development of nasal polyps and is a result of the increased recruitment of inflammatory cells, which are present in nasal polyps.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9042040     DOI: 10.1016/s0091-6749(97)70091-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  15 in total

1.  Human nasal polyp microenvironments maintained in a viable and functional state as xenografts in NOD-scid IL2rgamma(null) mice.

Authors:  Joel M Bernstein; Stephen P Brooks; Heather K Lehman; Liza Pope; Amy Sands; Leonard D Shultz; Richard B Bankert
Journal:  Ann Otol Rhinol Laryngol       Date:  2009-12       Impact factor: 1.547

2.  A Recently Established Murine Model of Nasal Polyps Demonstrates Activation of B Cells, as Occurs in Human Nasal Polyps.

Authors:  Dong-Young Kim; Sun Hye Lee; Roderick G Carter; Atsushi Kato; Robert P Schleimer; Seong H Cho
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

Review 3.  Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis.

Authors:  David D Tieu; Robert C Kern; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2009-07       Impact factor: 10.793

4.  Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease.

Authors:  Kathryn L Pothoven; James E Norton; Kathryn E Hulse; Lydia A Suh; Roderick G Carter; Erin Rocci; Kathleen E Harris; Stephanie Shintani-Smith; David B Conley; Rakesh K Chandra; Mark C Liu; Atsushi Kato; Nirmala Gonsalves; Leslie C Grammer; Anju T Peters; Robert C Kern; Paul J Bryce; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2015-04-01       Impact factor: 10.793

5.  Eosinophils and mast cells: a comparison of nasal mucosa histology and cytology to markers in nasal discharge in patients with chronic sino-nasal diseases.

Authors:  Moritz Gröger; Andreas Bernt; Maria Wolf; Brigitte Mack; Elisabeth Pfrogner; Sven Becker; Matthias F Kramer
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-22       Impact factor: 2.503

6.  Expression and distribution of epithelial sodium channel in nasal polyp and nasal mucosa.

Authors:  Yiming Jiang; Ji Xu; Yanqing Chen; Jiali Shi; Chun Zhang; Jiping Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-06       Impact factor: 2.503

Review 7.  Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases.

Authors:  Robert P Schleimer; Sergejs Berdnikovs
Journal:  J Allergy Clin Immunol       Date:  2017-06       Impact factor: 10.793

8.  Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease.

Authors:  Kathryn L Pothoven; James E Norton; Lydia A Suh; Roderick G Carter; Kathleen E Harris; Assel Biyasheva; Kevin Welch; Stephanie Shintani-Smith; David B Conley; Mark C Liu; Atsushi Kato; Pedro C Avila; Qutayba Hamid; Leslie C Grammer; Anju T Peters; Robert C Kern; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2016-12-18       Impact factor: 10.793

Review 9.  Pathogenesis of nasal polyposis.

Authors:  K E Hulse; W W Stevens; B K Tan; R P Schleimer
Journal:  Clin Exp Allergy       Date:  2015-02       Impact factor: 5.018

10.  Reconstituted human upper airway epithelium as 3-d in vitro model for nasal polyposis.

Authors:  Francisco de Borja Callejas; Asunción Martínez-Antón; Isam Alobid; Mireya Fuentes; Julio Cortijo; César Picado; Jordi Roca-Ferrer; Joaquim Mullol
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.